Rongsong Ling

1.0k total citations
20 papers, 617 citations indexed

About

Rongsong Ling is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Rongsong Ling has authored 20 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Immunology. Recurrent topics in Rongsong Ling's work include RNA modifications and cancer (7 papers), Cancer-related gene regulation (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Rongsong Ling is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related gene regulation (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Rongsong Ling collaborates with scholars based in China, Germany and South Korea. Rongsong Ling's co-authors include Yi-Zhou Jiang, Boxuan Huang, Demeng Chen, Wenjie Huang, Maosheng Cheng, Caihua Zhang, Shuang Chen, Xifeng Lu, Xiaochen Wang and Jianwen Chen and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Peptides.

In The Last Decade

Rongsong Ling

20 papers receiving 609 citations

Peers

Rongsong Ling
Comparison fields: 5 of 76
  • Molecular Biology 425
  • Cancer Research 159
  • Infectious Diseases 145
  • Oncology 100
  • Immunology 63
Replace Hua Cao with:
Hua Cao China
Kewen Qian China
Kepan Chen China
Takuya Morita Japan
Hongping Luo China
Changhua Yi China
Yanming Dong China
Sergei Pustylnikov United States
Michael D. Stutz Australia
Hua Cao China View profile →
Citations per field, relative to Rongsong Ling
Rongsong Ling · 1×
Citations per year, relative to Rongsong Ling
Rongsong Ling · 1×

Countries citing papers authored by Rongsong Ling

Since Specialization
Citations

This map shows the geographic impact of Rongsong Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongsong Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongsong Ling more than expected).

Fields of papers citing papers by Rongsong Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongsong Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongsong Ling. The network helps show where Rongsong Ling may publish in the future.

Co-authorship network of co-authors of Rongsong Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Rongsong Ling. A scholar is included among the top collaborators of Rongsong Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongsong Ling. Rongsong Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 3
3 6
4 14
5 11
6 25
7 16
8 7
9 5
10 18
11 11
12 133
13 125
14 7
15 41
16 13
17 62
18 89
19 23
20 7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026